Development of ErbB4 Agonists for Treatment of Heart Failure.
MicroRNA in heart failure: Exercise as a tool to discover candidate microRNA for therapy and personalized medicine.
Activating the neuregulin-1/ErbB4 pathway for treatment of heart failure.
Diagnostic and therapeutic potential of microRNA-181c in HFpEF.
Defining atrial myopathy in aging and disease (DIAMOND consortium).
Publication type
|
|
|
|
|